Recent Articles

Amazon Is A Big, Fat “Sell” – Here’s Why…

Greg Guenthner

Just one short year ago, investors were rejoicing at Amazon's huge bounce. But thanks to a blundered foray into the smartphone market and a drone delivery service that never materialized, Amazon has had a fairly rocky 2014. Today, Greg Guenthner explains why this stock is a sell, AHEAD of the holiday season. Read on...


Why Cancer Will Become a Manageable Chronic Health Condition

Ray Blanco

There's no doubt that biotech research has led to some truly astounding medical breakthroughs... especially with regards to cancer treatments. But just how far has this research come? What does it mean for the future of biotechnology? And how can you benefit from it? Ray Blanco answers each of these questions, right here...


5 Min. ForecastThe Best Performing Sector For the Rest of 2014

Dave Gonigam

Sure... Ebola is the disease du jour... And a lot of good research has gone into trying to combat it. But while most of that has been experimental, many proven cancer fighting drugs are finally coming to market. And that presents a very unique profit opportunity for savvy investors. Dave Gonigam explains...


Don’t Miss The Biggest Biotech Market EVER!

Paul Mampilly

You're likely to hear a lot of sad sack investors talk about the dangers of investing in biotech. Don't listen to them. According to Paul Mampilly, those crying "biotech bubble" are just sore losers. Today he explains why he's still very bullish on biotech stocks, and why he considers this the golden age of biotechnology investing. Read on...


The Secret Oil Price Rally No One’s Talking About

Greg Guenthner

If you believe the "evil geniuses" at Goldman Sachs, oil is now so plentiful that supply far outstrips demand and the oil price has nowhere to go but down. Of course, that's just what they want you to think... As Greg Guenthner points out, there is actually strong evidence to support an intermediate oil rally, if you know what to look for. Read on...


Why a Central Bank Can Never Run Out of Money

Chris Mayer

If you were to ask all of the world's economists and financial pundits to explain "modern money," most of them would probably get it wrong. Today, Chris Mayer offers a detailed description of what money really is, and how understanding it puts you one giant step ahead of most economists and investors. Read on...


Where GMOs Went Wrong – and Why You Should Avoid Them

Josh Grasmick

Recent advances in genetic engineering have allowed agri-business to grow bigger, more plentiful crops. But when does good, helpful technology overstep its bounds and become harmful? Today, Josh Grasmick explores how genetically modified foods (GMOs) have changed the world... both for good AND for ill. Read on...


Laissez FaireWeaponized Ebola: Not as Far-Fetched As You May Think

Chris Campbell

Only a few months before Sept. 11, 2001 a group of security experts got together to conduct one national security exercise. They called it Operation Dark Winter. Their question: What would happen in the event of a bioterrorist attack on the United States? The answer will shock you. Chris Campbell reveals what they discovered right here...


Why Biotech Stocks are Screaming “Buy Me” Right Now

Greg Guenthner

With so much volatility in the markets this month, and fear driving most of the trading, you might think it's a good time to sit on the sidelines and wait for the dust to settle a bit. Today, Greg Guenthner explains why that's the wrong attitude to have right now... especially with regard to biotech stocks. Read on...